NCT00889382 2024-11-20A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)Astellas Pharma IncPhase 1/2 Completed152 enrolled